The Rechts der Isar Hospital is a hospital in the Haidhausen district of Munich, Germany. It is the teaching hospital and biomedical research facility of the TUM School of Medicine.

There are 1,161 beds in Klinikum Rechts Der Isar - Technische Universitaet Muenchen.

During the past decade, Klinikum Rechts Der Isar - Technische Universitaet Muenchen conducted 164 clinical trials. In the 10-year time frame, 164 clinical trials started and 62 clinical trials were completed, i.e. on average, 37.8% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 38 clinical trials were completed. i.e. 84.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" #1 sponsor was "Technical University of Munich" with 30 trials, followed by "Celgene" with 15 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 11 trials sponsored, "Deutsches Herzzentrum Muenchen" with 9 trials sponsored and "German CLL Study Group" with 9 trials sponsored. Other sponsors include 235 different institutions and companies that sponsored additional 151 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" #1 collaborator was "Technical University of Munich" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator and "ClinAssess GmbH" with 3 trials as a collaborator. Other collaborators include 175 different institutions and companies that were collaborators in the rest 153 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" are "Ovarian Cancer" (11 trials), "Acute Myeloid Leukemia" (9 trials), "Myelodysplastic Syndromes" (9 trials), "Breast Cancer" (8 trials) and "Alzheimer's Disease" (7 trials). Many other conditions were trialed in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" in a lesser frequency.

Most popular intervention types in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" are "Drug" (215 trials), "Biological" (43 trials), "Other" (34 trials), "Device" (32 trials) and "Procedure" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (55 trials), "cyclophosphamide" (9 trials), "Lenalidomide" (8 trials), "Obinutuzumab" (8 trials) and "Pembrolizumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" are 272 trials for "All" genders, 28 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen". 2 are not yet recruiting, 45 are recruiting, 47 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 146 completed trials in Klinikum Rechts Der Isar - Technische Universitaet Muenchen, 2 suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Rechts Der Isar - Technische Universitaet Muenchen, 23 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 134 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 24 trials that are defined as “Not Applicable".